Latest filing published 21 Aug 2026 for Neumora Therapeutics, Inc., €57k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Aurora Daljit Singh discloses dealings in Neumora Therapeutics, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 17 August 2026 to 21 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 21 August 2026, reports a transaction of €57k in Neumora Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations